KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Acquisitions (2016 - 2025)

Boston Scientific (BSX) has disclosed Acquisitions for 16 consecutive years, with $89.0 million as the latest value for Q4 2025.

  • Quarterly Acquisitions fell 97.4% to $89.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, down 69.61% year-over-year, with the annual reading at $1.6 billion for FY2025, 65.67% down from the prior year.
  • Acquisitions hit $89.0 million in Q4 2025 for Boston Scientific, up from $73.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $3.4 billion in Q4 2024 to a low of $47.0 million in Q1 2024.
  • Historically, Acquisitions has averaged $663.8 million across 5 years, with a median of $321.5 million in 2021.
  • Biggest YoY gain for Acquisitions was 2002.08% in 2025; the steepest drop was 97.4% in 2025.
  • Year by year, Acquisitions stood at $244.0 million in 2021, then plummeted by 70.9% to $71.0 million in 2022, then skyrocketed by 1016.9% to $793.0 million in 2023, then surged by 331.02% to $3.4 billion in 2024, then plummeted by 97.4% to $89.0 million in 2025.
  • Business Quant data shows Acquisitions for BSX at $89.0 million in Q4 2025, $73.0 million in Q3 2025, and $1.0 billion in Q2 2025.